Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rapidly dividing cell is not a canonical molecular target, receptor, or specific protein, but rather a descriptive term for any cell population undergoing frequent cell division. Such cells are commonly found during embryonic development, tissue regeneration, and in pathological contexts like cancer. These cells are characterized by high rates of DNA synthesis, chromatin remodeling, and reduced levels of certain inhibitory histone modifications, making them epigenetically dynamic[1][5]. In cancer, cells that divide rapidly are often the primary targets of cytotoxic chemotherapies. The term does not refer to a specific molecular entity, but instead describes a physiological state or feature of a cell population[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rapidly dividing cell.